Israel Pharmacists,
טיפול כימותרפי אינו מועיל לנשים עם סוגים מסוימים מוקדמים של סרטן השד, כך מציע מחקר Phase III שפורסם ב-New England Journal of…
טיפול כימותרפי אינו מועיל לנשים עם סוגים מסוימים מוקדמים של סרטן השד, כך מציע מחקר Phase III שפורסם ב-New England Journal of…
自己和家人的健康,還是得靠自己多關心 根據史丹佛大學研究顯示:民眾經常服用醫師所開立的處方藥, 但這些處方有20%可能是錯誤的。 https://www.facebook.com/1586249091656912/posts/2085649811716835…
You and your family should take responsibility for your own…
This last week will be dedicated to articles published in 2018. To start off: Adjuvant Chemotherapy Guided by a 21-Gene…
The following brief summaries highlight some of the notable breast cancer stories thus far in 2018. Genetic assessment of…
從一個名為 TAILORx 分析 21 種基因檢測因子的臨床試驗結果顯示,有 70% 的乳癌病人並沒有從化療得到療效,其結果更進一步顯示,若是早期病人,且沒有淋巴轉移,再加上 ER 陽性且 HER2 陰性者,是可以在手術後不需要接受化學治療的。 原始文獻…
N Engl J Med. 2018 Jul 12;379(2):111-121. doi: 10.1056/NEJMoa1804710. Epub 2018 Jun 3. Equivalence Trial; Multicenter Study…
N Engl J Med. 2018 Jul 12;379(2):111-121. doi: 10.1056/NEJMoa1804710. Epub 2018 Jun 3. Equivalence Trial; Multicenter Study…
A genetic assay predicts a benefit of chemotherapy if the score is high and a low risk of recurrence without chemotherapy if it…
A genetic assay predicts a benefit of chemotherapy if the score is high and a low risk of recurrence without chemotherapy if it…
A genetic assay predicts a benefit of chemotherapy if the score is high and a low risk of recurrence without chemotherapy if it…
A genetic assay predicts a benefit of chemotherapy if the score is high and a low risk of recurrence without chemotherapy if it…
A genetic assay predicts a benefit of chemotherapy if the score is high and a low risk of recurrence without chemotherapy if it…
A genetic assay predicts a benefit of chemotherapy if the score is high and a low risk of recurrence without chemotherapy if it…
A genetic assay predicts a benefit of chemotherapy if the score is high and a low risk of recurrence without chemotherapy if it…
A genetic assay predicts a benefit of chemotherapy if the score is high and a low risk of recurrence without chemotherapy if it…
A genetic assay predicts a benefit of chemotherapy if the score is high and a low risk of recurrence without chemotherapy if it…
https://www.nejm.org/doi/full/10.1056/NEJMoa1804710?query=featured_home
According to a new study, most women with certain types of early breast cancer don't need chemo. Dr. Harold Burstein said in…
A new paper in the New England Journal of Medicine reports that genetic testing breast cancer tumor samples enabled many women…
Genetic Test Can Rule Out Chemo Use in Early Breast Cancer: Most women can get endocrine therapy alone based on Oncotype Dx…
Many women with common breast cancer can safely skip chemo-therapy, according to a recent study. http://bit.ly/2LDxQa8
"The 21-gene recurrence-score assay (Oncotype DX, Genomic Health) is one of several commercially available gene-expression…
New prospective trial on Oncotype DX for #BreastCancer suggests that women with mid-range #RecurrenceScore (11-25) can be…
自己和家人的健康,還是得靠自己多關心 根據研究顯示:民眾經常服用醫師所開立的處方藥,但這些處方有20%可能是錯誤的。 根據史丹佛大學研究顯示:民眾經常服用醫師所開立的處方藥,包括稀釋血液的阿斯匹靈aspirin, statins 斯達丁類降膽固醇藥物及降…
為何通常你應該避開癌症篩檢! 國際知名重量級的實證醫學專家 Peter Gøtzsche 醫師 給內行人看的視頻 : 為何通常你應該避開癌症篩檢( Why you should usually avoid cancer screening …
https://www.nejm.org/doi/full/10.1056/NEJMoa1804710
https://www.nejm.org/doi/full/10.1056/NEJMoa1804710#.WxRCsP1R24Y.linkedin
"The finding from a randomized clinical trial suggests a change in clinical practice for majority of women with disease that is…
rethinking breast cancer chemotherapy #ctisus https://www.nejm.org/doi/full/10.1056/NEJMoa1804710?query=featured_home
MANY WOMEN WITH EARLY BREAST CANCER MAY NOW BE ABLE TO AVOID CHEMOTHERAPY: According to a new international study published in…
Great news for many newly diagnosed patients with breast cancer!! Link to full article here: https://www.nejm.org/doi/pdf/10.105…
About 70% of women diagnosed with the early stages of one of the most common forms of breast cancer might not need chemotherapy…
About 70% of women diagnosed with the early stages of one of the most common forms of breast cancer might not need chemotherapy…
Great news for many newly diagnosed patients with breast cancer!! Link to full article here: https://www.nejm.org/doi/pdf/10.105…
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer | NEJM https://t.co/FPvdyWDRFK
Great news for many newly diagnosed patients with breast cancer!! Link to full article here: https://www.nejm.org/doi/pdf/10.105…
Quimioterapia adyuvante en cáncer de mama
#oncotype
What can one say other than this is good news... "Many women with early-stage breast cancer who would currently be treated with…
21-gene recurrence score が11-25のホルモンレセプター陽性 / HER2陰性 / リンパ節転移陰性乳がんにおいては、化学療法+ホルモン療法とホルモン療法単独の成績は同等 (文献2018-109)。 "Adjuvant…
Great news for many newly diagnosed patients with breast cancer!! Link to full article here: https://www.nejm.org/doi/pdf/10.105…
Great news for many newly diagnosed patients with breast cancer!! Link to full article here: https://www.nejm.org/doi/pdf/10.105…
#乳癌 #荷爾蒙受體陽性HER2受體陰性型 [新聞]美研究:約70%早期乳癌患者可免化療 婦女被診斷出早期「荷爾蒙受體陽性、HER2受體陰性型」乳癌,而又有中等復發風險時,往往不清楚是否需要在荷爾蒙療法以外接受化療。如今,醫生會以基因檢測分析乳癌未來10年…
Great news for estrogen receptor positive breast cancer patients who have tumors with an intermediate-risk Oncotype score! We…
Great news for estrogen receptor positive breast cancer patients who have tumors with an intermediate-risk Oncotype score! We…
When a genetic test was used to assess prognosis, women with midrange scores were found to have similar outcomes after adjuvant…